相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Karyotype complexity and prognosis in acute myeloid leukemia
F. Stoelzel et al.
BLOOD CANCER JOURNAL (2016)
inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations
Sebastian Schwind et al.
BLOOD (2013)
MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial
Hong-Hu Zhu et al.
BLOOD (2013)
Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial
John A. Liu Yin et al.
BLOOD (2012)
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
David Grimwade et al.
BLOOD (2010)
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
Jeffrey E. Rubnitz et al.
LANCET ONCOLOGY (2010)
Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan
Hiroto Narimatsu et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts
Luke F. Peterson et al.
BLOOD (2007)
Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]
G Perea et al.
LEUKEMIA (2006)
New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFB-MYH11+ acute myeloid leukemia based on quantification of fusion transcripts
S Schnittger et al.
BLOOD (2003)
Determination of minimal residual disease in leukaemia patients
D Campana
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia:: results from Cancer and Leukemia Group B (CALGB 8461)
JC Byrd et al.
BLOOD (2002)
Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia:: A multicenter study of 51 patients
F Morschhauser et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
